Wie man die anderen verstehen soll und wie man über sie schreiben kann. Der Paris-Bericht Rifāʿa Rāfiʿ aṭ-Ṭahṭāwīs (1801-1873) als vielseitige Vermittlung von 'Kultur'

Im vorliegenden Essay wird eine Lesart des viel diskutierten Paris-Berichts von Rifāʿa aṭ-Ṭahṭāwī vorgestellt. Kontrastierend zu der Annahme, Ṭahṭāwī habe eine Reise aus einer Kultur in eine andere unternommen, soll hier dargelegt werden, wie sich aus dem Text des Ägypters ein eigenes Kulturverständnis erschließen lässt. Besonders Ṭahṭāwīs Bemühungen um die Übersetzung des französischen Begriffs 'civilisation' deuten auf ein plurales Verständnis von 'Kultur'. Denn im Text lassen sich diejenigen Dimensionen des Begriffs 'Kultur' finden, die auch aus der europäischen Geistesgeschichte rekonstruiert werden können: Kultur als bestimmter Lebensstil, als Prozessbegriff zur Beschreibung gesellschaftlicher Entwicklung und als kreative oder künstlerische Aktivität.

Victims of War must be loyal to deserve protection: International law and national legislation on enemy aliens 1907-1918

In international law the internment of civilians has only been regulated in writing in the context of the 4th Geneva Convention of 1949. Nevertheless this did not mean that civilians were not protected by at least some rules of customary international law before that date and especially in World War I. Furthermore specialists of international law expected states – at least those considered to be part of the community of civilized nations – to continue to treat all men equal before the law even in wartime. As research already conducted (Bird, Panayi, Fischer) has shown, this was not the case during World War I. Based on these findings the presentation proposed here wants to look into the development of international law and into some national preparations for treating so called “enemy aliens” in the period before 1914 (Austria-Hungary, Australia, United Kingdom), in order to see to what extent principles of international law protecting civilians from the consequences of war can be detected in the pre-war preparations. As far as can be judged so far the issue of loyalty was central in this context. Looking at the war itself, the presentation proposed here will try to look at how far the principles of international law alluded to above continued to influence the policies on “enemy aliens” in the countries mentioned and to see, how the International Committee of the Red Cross tried to use them to legitimize and expand its protective policies in regard to civilians interned in belligerent as well as neutral countries throughout the war.

Association of long-term nicotine abstinence with normal metabotropic glutamate receptor-5 binding

BACKGROUND Nicotine addiction is a major public health problem and is associated with primary glutamatergic dysfunction. We recently showed marked global reductions in metabotropic glutamate receptor type 5 (mGluR5) binding in smokers and recent ex-smokers (average abstinence duration of 25 weeks). The goal of this study was to examine the role of mGluR5 downregulation in nicotine addiction by investigating a group of long-term ex-smokers (abstinence >1.5 years), and to explore associations between mGluR5 binding and relapse in recent ex-smokers. METHODS Images of mGluR5 receptor binding were acquired in 14 long-term ex-smokers, using positron emission tomography with radiolabeled [11C]ABP688, which binds to an allosteric site with high specificity. RESULTS Long-term ex-smokers and individuals who had never smoked showed no differences in mGluR5 binding in any of the brain regions examined. Long-term ex-smokers showed significantly higher mGluR5 binding than recent ex-smokers, most prominently in the frontal cortex (42%) and thalamus (57%). CONCLUSIONS Our findings suggest that downregulation of mGluR5 is a pathogenetic mechanism underlying nicotine dependence and the high relapse rate in individuals previously exposed to nicotine. Therefore, mGluR5 receptor binding appears to be an effective biomarker in smoking and a promising target for the discovery of novel medication for nicotine dependence and other substance-related disorders.